Literature DB >> 27445098

Diabetic kidney disease: Is there a non-albuminuric phenotype in type 2 diabetic patients?

Ivo Laranjinha1, Patrícia Matias2, Sofia Mateus3, Filipa Aguiar3, Patrícia Pereira3, Miguel Perneta Santos3, Rui Costa3, Ana Lourenço3, José Guia3, José Diogo Barata2, Luís Campos3.   

Abstract

BACKGROUND: Albuminuria was widely considered as the first clinical sign of diabetic kidney disease (DKD), which is why it has traditionally been used as a screening test for DKD. However, increasing evidence has shown that a significant number of type 2 diabetes mellitus (DM) patients have a decreased glomerular filtration rate (GFR) without significant albuminuria, known as non-albuminuric DKD (NA-DKD). The aim of this study was to determine the prevalence and the demographic and clinical characteristics of patients with NA-DKD.
METHODS: This was a 1-year retrospective study that included 146 type 2 diabetic patients with GFR<75mL/min followed-up in a diabetes outpatient department. Patients were divided into two groups according to their ACR status - NA-DKD and albuminuric DKD (A-DKD).
RESULTS: Of the 146 patients included in the study, 53.4% had A-DKD and 46.6% had NA-DKD. According to the multivariable analysis performed, patients with NA-DKD tended to be older (p=0.021), female (p=0.045) and with a lower GFR (p=0.004) than A-DKD patients. There was no difference between the groups in terms of body mass index, metabolic control of DM, duration of DM diagnosis and prevalence of metabolic syndrome.
CONCLUSIONS: The majority of patients with DKD had albuminuria, but a significant proportion had a non-albuminuric phenotype (46.6% in this population). These patients exhibit distinct clinical features that could have screening, therapeutic and prognosis implications.
Copyright © 2016 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Chronic kidney disease; Diabetes tipo 2; Enfermedad renal crónica; Non-albuminuria; Sin albuminuria; Type 2 diabetes

Mesh:

Year:  2016        PMID: 27445098     DOI: 10.1016/j.nefro.2016.03.025

Source DB:  PubMed          Journal:  Nefrologia        ISSN: 0211-6995            Impact factor:   2.033


  8 in total

1.  Comparison of Nonalbuminuric and Albuminuric Diabetic Kidney Disease Among Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Authors:  Shaomin Shi; Lihua Ni; Ling Gao; Xiaoyan Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-03       Impact factor: 6.055

2.  The Relationship between Generalized and Abdominal Obesity with Diabetic Kidney Disease in Type 2 Diabetes: A Multiethnic Asian Study and Meta-Analysis.

Authors:  Ryan Eyn Kidd Man; Alfred Tau Liang Gan; Eva Katie Fenwick; Preeti Gupta; Mark Yu Zheng Wong; Tien Yin Wong; Gavin Siew Wei Tan; Boon Wee Teo; Charumathi Sabanayagam; Ecosse Luc Lamoureux
Journal:  Nutrients       Date:  2018-11-05       Impact factor: 5.717

3.  Association of the IgG N-glycome with the course of kidney function in type 2 diabetes.

Authors:  Sunny S Singh; Ralph Heijmans; Claudia K E Meulen; Aloysius G Lieverse; Olga Gornik; Eric J G Sijbrands; Gordan Lauc; Mandy van Hoek
Journal:  BMJ Open Diabetes Res Care       Date:  2020-04

Review 4.  Update on pathogenesis and diagnosis flow of normoalbuminuric diabetes with renal insufficiency.

Authors:  Le Deng; Wenjie Li; Gaosi Xu
Journal:  Eur J Med Res       Date:  2021-12-11       Impact factor: 2.175

5.  FcER1: A Novel Molecule Implicated in the Progression of Human Diabetic Kidney Disease.

Authors:  Swastika Sur; Mark Nguyen; Patrick Boada; Tara K Sigdel; Hans Sollinger; Minnie M Sarwal
Journal:  Front Immunol       Date:  2021-12-01       Impact factor: 7.561

6.  Letter Regarding "Moderating Effects in Randomized Trials-Interpreting the P Value, Confidence Intervals, and Hazard Ratios".

Authors:  Jorge Rico-Fontalvo; Rodrigo Daza-Arnedo; Maria Raad-Sarabia; José Restom-Arrieta; José Bohórquez-Rivero
Journal:  Kidney Int Rep       Date:  2022-03-04

7.  The modern spectrum of biopsy-proven renal disease in Chinese diabetic patients-a retrospective descriptive study.

Authors:  Diankun Liu; Ting Huang; Nan Chen; Gang Xu; Ping Zhang; Yang Luo; Yongping Wang; Tao Lu; Long Wang; Mengqi Xiong; Jian Geng; Sheng Nie
Journal:  PeerJ       Date:  2018-03-27       Impact factor: 2.984

8.  Neutrophil count as a reliable marker for diabetic kidney disease in autoimmune diabetes.

Authors:  Yao Yu; Qiuqiu Lin; Dewei Ye; Yanfei Wang; Binbin He; Yanhua Li; Gan Huang; Zhiguang Zhou; Yang Xiao
Journal:  BMC Endocr Disord       Date:  2020-10-22       Impact factor: 2.763

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.